HMI-115 for Endometriosis Pain
Recruiting0 awardsPhase 2
Shawnee Mission, Kansas
This trial is testing HMI-115, a new treatment for reducing pain from endometriosis. It focuses on pre-menopausal women who have moderate to severe pain. The study will test different doses to find the safest and most effective amount.
Anti-infective Agent
Metronidazole for Postoperative Pain in Endometriosis
Recruiting2 awardsPhase 4
Louisville, Kentucky
This trial is testing if taking the antibiotic metronidazole can reduce pain after endometriosis surgery in women aged 18-50. The antibiotic works by killing bacteria to prevent infections, which might help with pain relief.
Dopamine Agonist
Cabergoline for Endometriosis
Recruiting2 awardsPhase 2
Boston, Massachusetts
This trial is testing cabergoline, a medication that stops new blood vessels from forming, to see if it can reduce pain in adolescents and young women with endometriosis. Current treatments often don't work well or have too many side effects. Cabergoline may offer a safer, long-term solution by preventing the growth of new blood vessels needed for endometriosis to grow. Cabergoline has shown promise in early studies for treating chronic pain due to endometriosis.
Behavioural Intervention
Repetitive Transcranial Magnetic Stimulation for Endometriosis Pain
Recruiting0 awards
Ottawa, Ontario
This trial aims to improve pain outcomes for Canadian women with endometriosis. It will test the effectiveness of a repetitive transcranial magnetic stimulation (rTMS) intervention for reducing pain in individuals
Antiplatelet Agent
Aspirin for Endometriosis
Recruiting2 awardsPhase 4
University Park, Pennsylvania
This trial will compare blood pressure, pain, and platelet activity in women with and without endometriosis during certain tests. Participants will take aspirin and/or placebo and undergo exercise, cold pressor tests, iontophoresis, and blood draw.
Popular Filters
Trials for Pelvic Pain Patients
N/A
Hyivy Device for Endometriosis
Recruiting1 award12 criteria
Hamilton, Ontario
This trial is testing the Hyivy device, which is designed to help reduce pelvic pain. The study focuses on people with endometriosis, a condition that causes significant pelvic pain. The device likely uses physical therapy methods to ease this pain.
Behavioural Intervention
Group Care Program for Endometriosis
Recruiting1 award5 criteria
Saint Louis, Missouri
This trial tests a program to help people with endometriosis-related pelvic pain reduce their pain and improve their quality of life. It includes peer support, education, mindfulness, and yoga.
Behavioral Intervention
Peer Empowered Endometriosis Pain Support for Endometriosis
Recruiting1 award4 criteria
Saint Louis, Missouri
This trial aims to see if a program called Peer Empowered Endometriosis Pain Support (PEEPS) can help reduce pain in women with endometriosis-associated chronic pelvic pain. They will
Behavioral Intervention
Online Self-Management Program for Chronic Pelvic Pain
Recruiting1 award
Ann Arbor, Michigan
This trial aims to see if an online self-management program can help patients with Chronic Pelvic Pain feel better. The researchers believe that patients using the program will have less pain, better physical function, and
Phase 3 Trials
GnRH Antagonist
Pre-IVF GnRH Antagonist for Endometriosis-related Infertility
Recruiting1 awardPhase 3
Aurora, Colorado
This trial tests a pill that helps women with endometriosis who are undergoing IVF. These women often have lower success rates with IVF, and the pill helps manage hormone levels to improve their chances of having a baby.
Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist
Relugolix for Uterine Fibroids
Recruiting2 awardsPhase 3
Mobile, Alabama
This trial aims to understand how a 4-year treatment with a relugolix combination tablet affects bone mineral density in premenopausal women with heavy bleeding or endometriosis pain.
Trials With No Placebo
Mindfulness for Endometriosis
Recruiting1 award3 criteria
Hershey, Pennsylvania
This trial aims to test a brief mindfulness-based intervention for women with endometriosis-related chronic pelvic pain who are undergoing surgical treatment. The study will enroll 10-20 adult participants with this condition
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.